Fermentek manufactures bioactive compounds by the means of Fermentation technology. Our products are directed for the biological research, in the areas of molecular biology, applied medical research, and, in bulk amounts, for preclinical trials and for drug discovery. Fermentek's aim is to make already known compounds, affordable to the scientific community. The products intended for drug discovery are produced under GMP/API regime. To make our products, we use Streptomycetes and some other bacteria from soil, Molds (fungi) such as Aspergillus, Penicillium, Fusaria. Several products are derived from plants. Our newest products are: staurosporine derivate PKC412, mycotoxins. Our research struggles to enrich the mycotoxin line and include more food safety relevant products. The mycotoxin products are mostly sold to food safety laboratories.Recently, Fermentek has announced a whole series of products: pre-calibrated, certified standard solutions of most important mycotoxins. These are marketed under the name FermaSol.Fermentek Biotechnology was founded by Dr Yosef Behrend in 1995. Fermentek is located in the Atarot industrial zone in Jerusalem, Israel. We are a manufacturer, not a reseller or a distributor. With few exeptions, all our products are made in house. The majority of our products is sold to major chemicals trading companies who resell it under their own trade names. The lesser part is sold directly to the end-users who apply to us via the Internet. Among these are university research and government research bodies, drug discovery companies, and major pharmaceutical manufacturers. All are equally welcome. However, we do not accept one time orders below $500. We do not sell to individuals. We are the one of the very few manufacturers of Mycotoxins reference standards. For instance, we are the only ones that make Aflatoxin M2.